PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Idioma
EN
Article de revue
Este ítem está publicado en
Acta Neuropathologica. 2020, vol. 139, n° 6, p. 1025-1044
Resumen en inglés
pinnings, we identified a network of co-expressed proteins connecting PLCG2 to APOE and TREM2 using unsupervised co-regulatory network analysis. The network was highly enriched for the complement cascade and genes ...Leer más >
pinnings, we identified a network of co-expressed proteins connecting PLCG2 to APOE and TREM2 using unsupervised co-regulatory network analysis. The network was highly enriched for the complement cascade and genes differentially expressed in disease-associated microglia. Our data show that p.P522R in PLCG2 reduces AD disease progression by mitigating tau pathology in the presence of amyloid pathology and, as a consequence, maintains cognitive function. Targeting the enzyme PLCG2 might provide a new therapeutic approach for treating AD.< Leer menos
Palabras clave
SEPIA
HEALTHY
Centros de investigación